Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT ID: NCT05115981
Last Updated: 2022-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1930 participants
OBSERVATIONAL
2022-01-24
2022-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medical Students and Psychoactive Substances Use
NCT04209101
Current Situation on the Consumption of Hypnotic Substances at the Pharmacy
NCT02896153
French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
NCT02954679
New Psychoactive Substances in Intoxicated Patients During the Winter Activities
NCT04155281
ORiginal meThodology for Assessing the Impact of the Coronavirus Health Crisis on Psychotropic Drug Use
NCT05395897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Studying medicine or pharmacy in France from the 2nd to the 6th year
* Have read the newsletter and validated its no objection
* Have answered all the questions
* Validate the return of the questionnaire
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grenoble_Alpes UniversityHospital
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01352-37
Identifier Type: OTHER
Identifier Source: secondary_id
38RC20.161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.